GlaxoSmithKline starts late-stage trial for experimental antibiotic

GlaxoSmithKline starts late-stage trial for experimental antibiotic

FILE PHOTO: The GSK logo is seen on top of GSK Asia House in Singapore
FILE PHOTO: The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. REUTERS/Loriene Perera/File Photo

LONDON: GlaxoSmithKline Plc said on Monday (Oct 28) it has begun a late-stage study testing its experimental antibiotic in patients with urinary tract infection and gonorrhea, a type of sexually transmitted infection.

The antibiotic, gepotidacin, is the first of a new class of drugs and is expected to treat the two common infections caused by bacteria - identified as antibiotic resistant threats by US health regulators.

Health officials across the world have called for the development of newer versions of antibiotics as the growing problem of antibiotic resistance renders some of the most commonly prescribed treatments ineffective.

Source: Reuters/nc

Bookmark